1. Sedighi M, Baluchnejadmojarad T, Fallah S, et al. Klotho Ameliorates Cellular Inflammation via Suppression of Cytokine Release and Upregulation of miR-29a in the PBMCs of Diagnosed Alzheimer's Disease Patients. Journal of molecular neuroscience : MN 2019; 69: 157-165. 2019/06/15. DOI: 10.1007/s12031-019-01345-5.
2. Johnson KA, Fox NC, Sperling RA, et al. Brain imaging in Alzheimer disease. Cold Spring Harbor perspectives in medicine 2012; 2: a006213-a006213. DOI: 10.1101/cshperspect.a006213.
3. Vemuri P, Whitwell JL, Kantarci K, et al. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. NeuroImage 2008; 42: 559-567. 2008/05/20. DOI: 10.1016/j.neuroimage.2008.05.012.
4. Pini L, Pievani M, Bocchetta M, et al. Brain atrophy in Alzheimer’s Disease and aging. Ageing Research Reviews 2016; 30: 25-48. DOI: https://doi.org/10.1016/j.arr.2016.01.002.
5. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. 2010, p. 1118-1127.
6. Whitwell JL. Progression of Atrophy in Alzheimer ’ s Disease and Related Disorders. 2010: 339-346. DOI: 10.1007/s12640-010-9175-1.
7. Berron D, van Westen D, Ossenkoppele R, et al. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease. Brain 2020; 143: 1233-1248. DOI: 10.1093/brain/awaa068.
8. Stranahan AM and Mattson MP. Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plasticity 2010; 2010. DOI: 10.1155/2010/108190.
9. Scheff SW, Price DA, Ansari MA, et al. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. Journal of Alzheimer's Disease 2015; 43: 1073-1090. DOI: 10.3233/JAD-141518.
10. Bejanin A, La Joie R, Landeau B, et al. Distinct Interplay between Atrophy and Hypometabolism in Alzheimer's Versus Semantic Dementia. Cerebral Cortex 2019; 29: 1889-1899. DOI: 10.1093/cercor/bhy069.
11. Camarda C, Torelli P, Pipia C, et al. Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study. Current Alzheimer research 2018; 15: 1013-1026. DOI: 10.2174/1567205015666180702111110.
12. Burton EJ, McKeith IG, Burn DJ, et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain : a journal of neurology 2004; 127: 791-800. DOI: 10.1093/brain/awh088.
13. Weiler M, Agosta F, Canu E, et al. Following the spreading of brain structural changes in Alzheimer's disease: A longitudinal, multimodal MRI study. Journal of Alzheimer's Disease 2015; 47: 995-1007. DOI: 10.3233/JAD-150196.
14. Fiford CM, Sudre CH, Pemberton H, et al. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change. Neuroinformatics 2020; 18: 429-449. 2020/02/18. DOI: 10.1007/s12021-019-09439-6.
15. Korte N, Nortley R and Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. Acta Neuropathologica 2020; 140: 793-810. DOI: 10.1007/s00401-020-02215-w.
16. Mattsson N, Tosun D, Insel PS, et al. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain 2014; 137: 1550-1561. DOI: 10.1093/brain/awu043.
17. Jack Jr CR, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003; 60: 253-260. DOI: 10.1212/01.wnl.0000042480.86872.03.
18. Kim CM, Alvarado RL, Stephens K, et al. Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment. Neurobiology of aging 2020; 86: 64-74. 2019/12/10. DOI: 10.1016/j.neurobiolaging.2019.10.023.
19. Shirayama Y, Takahashi M, Oda Y, et al. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine. Brain imaging and behavior 2019; 13: 75-86. 2017/12/17. DOI: 10.1007/s11682-017-9803-y.
20. Wierenga CE, Dev SI, Shin DD, et al. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012; 32: 1589-1599. 2012/05/03. DOI: 10.1038/jcbfm.2012.58.
21. Wolk DA and Detre JA. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Current opinion in neurology 2012; 25: 421-428. 2012/05/23. DOI: 10.1097/WCO.0b013e328354ff0a.
22. Wolters FJ, Zonneveld HI, Hofman A, et al. Cerebral Perfusion and the Risk of Dementia: A Population-Based Study. Circulation 2017; 136: 719-728. 2017/06/08. DOI: 10.1161/circulationaha.117.027448.
23. Pettigrew C, Soldan A, Zhu Y, et al. Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage Clin 2016; 12: 116-122. DOI: 10.1016/j.nicl.2016.06.010.
24. Parker TD, Slattery CF, Zhang J, et al. Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging. Human brain mapping 2018; 39: 3005-3017. 2018/03/27. DOI: 10.1002/hbm.24056.
25. Li C, Wang J, Gui L, et al. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's disease : JAD 2011; 27: 281-290. 2011/07/30. DOI: 10.3233/jad-2011-110497.
26. Lee YW, Lee H, Chung IS, et al. Relationship between postural instability and subcortical volume loss in Alzheimer's disease. Medicine 2017; 96: e7286. 2017/06/24. DOI: 10.1097/md.0000000000007286.
27. Buckner RL, Andrews-Hanna JR and Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences 2008; 1124: 1-38. 2008/04/11. DOI: 10.1196/annals.1440.011.
28. Moskowitz MA, Lo EH and Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010; 67: 181-198. DOI: 10.1016/j.neuron.2010.07.002.
29. Park L, Anrather J, Zhou P, et al. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 2005; 25: 1769-1777. DOI: 10.1523/JNEUROSCI.5207-04.2005.
30. Niwa K, Younkin L, Ebeling C, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 9735-9740. 2000/08/16. DOI: 10.1073/pnas.97.17.9735.
31. Niwa K, Kazama K, Younkin L, et al. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. American journal of physiology Heart and circulatory physiology 2002; 283: H315-323. 2002/06/14. DOI: 10.1152/ajpheart.00022.2002.
32. Chow N, Bell RD, Deane R, et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 823-828. 2007/01/12. DOI: 10.1073/pnas.0608251104.
33. Michels L, Warnock G, Buck A, et al. Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2016; 36: 581-595. 2015/12/15. DOI: 10.1177/0271678x15605847.
34. Kim SM, Kim MJ, Rhee HY, et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 2013; 55: 25-34. 2012/07/26. DOI: 10.1007/s00234-012-1077-x.
35. Cheng CP, Cheng ST, Tam CW, et al. Relationship between Cortical Thickness and Neuropsychological Performance in Normal Older Adults and Those with Mild Cognitive Impairment. Aging and disease 2018; 9: 1020-1030. 2018/12/24. DOI: 10.14336/ad.2018.0125.
36. Yi HA, Möller C, Dieleman N, et al. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry 2016; 87: 425-432. 2015/04/24. DOI: 10.1136/jnnp-2014-309105.
37. Luckhaus C, Cohnen M, Flüss MO, et al. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry research 2010; 183: 44-51. 2010/06/15. DOI: 10.1016/j.pscychresns.2010.04.003.
38. Montal V, Vilaplana E, Alcolea D, et al. Cortical microstructural changes along the Alzheimer's disease continuum. Alzheimer's and Dementia 2018; 14: 340-351. DOI: 10.1016/j.jalz.2017.09.013.
39. Wirth M, Pichet Binette A, Brunecker P, et al. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2017; 37: 814-824. 2016/07/20. DOI: 10.1177/0271678X16641128.